BlowTab sodium starch glycolate corn-base Type B is metered into a high-shear granulator before aqueous binder addition in immediate-release tablet manufacturing. Total disintegrant loading is held between 2.0 wt% and 8.0 wt% of the dried granule mass, with the lower end reserved for formulations containing mannitol or dicalcium phosphate dihydrate and the upper end used for high-dose actives that form dense, slow-wetting granule compacts. A 300 L top-driven high-shear granulator with impeller tip speed in the 3 m/s to 8 m/s range and chopper speed near 1,500 rpm is charged with the active, filler, dry binder, and BlowTab intragranular fraction before purified water is sprayed at a rate that maintains wet mass consistency without forming paste balls. Wet mass is transferred to a fluid-bed dryer operating at 60 °C ± 5 °C inlet air temperature and dried until loss on drying falls below 2.0 wt%. The dried granule is milled through a 0.8 mm to 1.25 mm screen, blended with the extragranular BlowTab portion and magnesium stearate for 3 min to 5 min, then compressed on a rotary press at 10 kN to 25 kN to a tablet hardness of 50 N to 100 N. Disintegration is tested per USP <701> in 900 mL purified water at 37 °C ± 2 °C, and dissolution release is assessed by USP <711> Apparatus II at 50 rpm in 900 mL of 0.1 N HCl. The main processing conflict in high-shear wet granulation is premature swelling of the intragranular disintegrant during binder addition, which reduces the wicking reserve that should remain for the finished tablet; this is controlled by delaying the final injection of binder solution after the wet mass has reached a short dough stage and by using the corn-base Type B grade because its lower cold-water viscosity produces less binder thickening than potato-base Type A.

When Does the Intragranular to Extragranular Ratio Shift Disintegration from Surface Swelling to Capillary Wicking?

The split placement of BlowTab sodium starch glycolate between the granule interior and the extragranular compression blend is not functionally neutral. With a total addition of 4.0 wt% in a lactose/cellulose immediate-release tablet, an intragranular-heavy split of 75:25 embeds the disintegrant inside a binder film formed during wet massing; upon exposure to dissolution medium, the initial liquid penetration is slower because the granule exteriors must first soften, and the primary disintegration mechanism shifts toward swelling-induced granule fracture rather than rapid wicking through the compact. In contrast, moving to a 50:50 intragranular-to-extragranular split distributes BlowTab along the intergranular boundaries formed during compression, so water enters through direct contact with the disintegrant particles and generates a capillary network that fragments the tablet before granule surface hydration is complete. This change is observable as a reduction in disintegration time when tested under USP <701> in purified water, but it is accompanied by a loss of granule dilution protection and can produce higher ejection force on the rotary press if the extragranular BlowTab is poorly mixed with magnesium stearate. The practical operating window for most high-shear granulated formulations is a 40:60 to 60:40 split because the intragranular portion stabilizes granule porosity during drying while the extragranular portion preserves the fast wicking response. If blending time exceeds 5 min after lubricant addition, the hydrophobic layer on the alkaline-earth metal stearate coats BlowTab particles and suppresses the wicking mechanism, producing extended disintegration rather than the intended fast release. Published equipment-scale data for a 300 L high-shear granulator confirm that granule bulk density increases with intragranular BlowTab loading above 3.0 wt%, but the corresponding tablet tensile strength falls when the extragranular fraction is reduced below 1.5 wt% because intergranular contact zones become less disrupted. The consequence is a narrow processing corridor where both disintegration kinetics and compact strength remain acceptable without requiring reformulation.

For hard gelatin and hypromellose capsule fills, BlowTab potato-base Type A is blended into dry powder formulations at 2.0 wt% to 5.0 wt% relative to the filled mass, with the specific level determined by the capsule shell composition and the drug-loading ratio. Gelatin shells in the presence of high humidity or incompatible hygroscopic fillers can cross-link and delay shell rupture, while hypromellose shells tend to hydrate more slowly in acidic media; the water-insoluble, cross-linked carboxymethyl starch particles of BlowTab act as internal wicking channels that draw gastric fluid into the powder bed once the shell dissolves or ruptures. Capsule formulations containing hydrophobic lubricants such as magnesium stearate above 0.5 wt% benefit from pre-blending BlowTab with the filler for 5 min before lubricant addition because this sequence reduces particle surface coating and maintains rapid wetting of the disintegrant. The blended powder is filled on an automatic dosator or tamping-pin capsule machine, and the finished capsules are tested for disintegration by USP <701> with disks to prevent floating. Dissolution is monitored using USP <711> Apparatus II at 50 rpm in 900 mL of 0.1 N HCl for immediate-release capsules, with sampling at predetermined intervals to track the release front through the disintegrated mass. A process-specific failure mode in capsule lines occurs when Type A potato grade is over-loaded above 5.0 wt% in low-density powder blends because the larger potato starch granules can segregate during machine vibration, leading to variable fill weight and non-uniform disintegration among capsules. Pre-sieving through a 0.5 mm screen and maintaining relative humidity below 60% during filling minimize electrostatic adhesion of BlowTab to contact surfaces of the capsule machine.

Potato-Starch Type A Water Uptake in Direct Compression

BlowTab potato-base Type A differs from the corn-base Type B not only in botanical source but also in the physical geometry of the swollen particle network that forms during direct compression. Potato starch granules are larger and contain more amorphous regions after carboxymethylation and cross-linking, which gives Type A a faster initial water uptake when contact with aqueous media occurs. In a direct compression matrix using microcrystalline cellulose and dibasic calcium phosphate anhydrous, addition of Type A at 3.0 wt% to 5.0 wt% produces tablet swelling that is more localized to the disintegrant domains, while the corn-base Type B at the same addition produces a more distributed wicking response with less localized dimensional change. The direct compression process is run on a rotary press at 12 kN to 18 kN with a precompression stage of 4 kN to 6 kN to expel air before final compression; this sequence is especially important when Type A is used because its higher swelling capacity can otherwise trap air in the tablet and increase lamination tendency at higher press speeds. Tablet hardness is monitored in the 60 N to 90 N range, and friability is tested per USP <1216> for not more than 1.0% weight loss. The direct compression formulation containing Type A shows a sharper reduction in disintegration time as the disintegrant level increases from 2.0 wt% to 4.0 wt%, whereas the corn-base Type B effect plateaus earlier; this behavior is consistent with the different granule swelling velocities observed in particle-size-controlled dispersions. Under high-speed tableting above 80,000 tablets/h, Type A can cause weight variation due to its lower bulk flow in some direct compression blends, so the use of a forced feeder with rotating cage paddles is recommended to maintain die filling uniformity. If tablet moisture exceeds 3.0% after storage at 40 °C/75% RH in open containers, the swelling response of Type A diminishes because partial hydration has already occurred before administration.

When granulated sachet solids and dry syrup intermediates are formulated for reconstitution in water or fruit juice, BlowTab sodium starch glycolate is added at 1.0 wt% to 3.0 wt% to accelerate dispersion without creating a pasty sediment layer. The granule carrier is typically sucrose or dextrose-based, produced by fluid-bed top-spray granulation with a binder solution of povidone or hydroxypropyl methylcellulose; BlowTab is introduced in the final dry blending step after drying and screening so that its rapid hydration capacity is not consumed during the granulation process. Dissolution testing of the reconstituted suspension is performed with USP <711> Apparatus III or IV, but the more relevant quality control is the manual or automated dispersion time in 100 mL of water at 25 °C, which should be below 60 s for well-optimized sachet granules. Sodium starch glycolate absorbs water quickly and causes the granule bed to break apart through localized swelling and particle deaggregation, but above 3.0 wt% the excess swollen starch can raise the apparent viscosity of the reconstituted liquid and leave a sticky residue on the container wall. Storage stability at 30 °C/65% RH in aluminium foil laminate sachets is necessary because moisture ingress increases the loss on drying of the granule mass and prematurely activates the disintegrant, reducing the dispersion rate when the sachet is eventually opened. If the relative humidity in the production suite exceeds 60%, pre-drying of the intermediate material in a fluid-bed dryer at 50 °C to 55 °C for 30 min to 45 min is required before the final blending and pouch filling steps. Granule size distribution is controlled between 180 µm and 500 µm by screening through 35-mesh and 80-mesh sieves, because fine particles containing BlowTab create dust and product loss during the filling operation.

If sodium starch glycolate is assessed for dry powder injectable carriers, particulate-loading thresholds supersede conventional swelling performance

BlowTab sodium starch glycolate is water-insoluble and contains cross-linked starch particles that remain as discrete solid domains after reconstitution; this property precludes its use in aqueous injectable solutions meant for intravenous administration because the particulate burden is incompatible with normal parenteral safety expectations. If a dry powder for injection or a lyophilized cake is evaluated with BlowTab as a swelling or suspending aid, the formulation must satisfy the subvisible particulate limits of USP <788> for small-volume parenterals, specifically not more than 6,000 particles per container at 10 µm or greater and not more than 600 particles per container at 25 µm or greater, and visible particulate control under USP <790> must also be demonstrated. Sterilization of the dry powder by gamma irradiation or ethylene oxide can alter the swelling capacity of sodium starch glycolate through chain scission or surface oxidation, so the post-sterilization swelling volume must be checked against the unirradiated control using the sedimentation volume or water uptake method described in the sodium starch glycolate monograph. Terminal sterilization of a lyophilized cake containing sodium starch glycolate is further complicated by the tendency of the starch particles to retain moisture and generate localized expansion during freeze-drying, which can fracture the cake structure if the disintegrant content exceeds 1.0 wt% of the dry solid mass. Published data for sodium starch glycolate in approved parenteral products is limited, and the material is not commonly listed as an approved parenteral excipient in major regulatory compendia; therefore, any parenteral application requires toxicological qualification and a justification that no alternative soluble disintegrant or suspending agent exists. The operational boundary is clear: sodium starch glycolate performs its intended swelling function in solid oral dosage forms, while the particulate nature and swelling-induced rheology changes make it unsuitable for routine parenteral solutions unless the formulation is designed as a dry powder with rigorous particle-size control and the clinical route is intramuscular or subcutaneous rather than intravenous.

Under reduced compression force conditions, orally disintegrating tablets containing BlowTab sodium starch glycolate require a different disintegrant optimization strategy than conventional immediate-release tablets. BlowTab is added at 2.0 wt% to 5.0 wt% together with mannitol, crospovidone, or low-substituted hydroxypropyl cellulose to generate a tablet that disintegrates rapidly in the oral cavity without the need for water intake. The compression force on the rotary press is deliberately limited to 7 kN to 12 kN because higher compaction reduces the pore connectivity that BlowTab uses for capillary wicking; the resulting tablet hardness is generally in the 30 N to 60 N range, and friability must remain below 1.0% per USP <1216> to survive packaging and transport. In vitro disintegration is measured in 5 mL of purified water at 37 °C ± 2 °C with a 30 s acceptance target, while dissolution of the active is evaluated by USP <711> Apparatus II at 50 rpm in 900 mL of 0.1 N HCl or simulated saliva at pH 6.8. The corn-base Type B grade is preferred in orally disintegrating tablets because its smaller particle size imparts a smoother mouthfeel and less grittiness than potato-base Type A, which can be detected by patients if the larger starch granules are not fully wetted. Mannitol-based orally disintegrating tablets with BlowTab at 4.0 wt% show rapid buccal dispersal, but the formulation must be protected from moisture during storage in cold-form foil or polyvinyl chloride blisters with desiccant because the disintegrant absorbs moisture and slowly loses its rapid swelling capacity at relative humidity above 40%. A production-scale failure mode in orally disintegrating tablet manufacturing is edge picking or sticking to the punch faces caused by inadequate magnesium stearate lubrication; this friction disrupts the tablet surface and reduces the speed of salivary penetration, so the lubricant level is kept between 0.25 wt% and 0.50 wt% and blending time is limited to 3 min to avoid overcoating BlowTab with hydrophobic material.